{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:36Z","timestamp":1786997916362,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.urology.2016.04.049","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T13:18:38Z","timestamp":1463491118000},"page":"143-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Peyronie's Disease and Injectable Collagenase Clostridium histolyticum: Safety, Efficacy, and Improvements in Subjective Symptoms"],"prefix":"10.1016","volume":"94","author":[{"given":"Kevin K.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2016.04.049_bib0010","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0022-5347(01)64222-8","article-title":"Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction","volume":"158","author":"Jarow","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.04.049_bib0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-5347(01)65367-9","article-title":"Fibrin deposition in Peyronie's disease plaque","volume":"157","author":"Somers","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.04.049_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/282503","article-title":"A population-based study of Peyronie's disease: prevalence and treatment patterns in the United States","volume":"2011","author":"Dibenedetti","year":"2011","journal-title":"Adv Urol"},{"key":"10.1016\/j.urology.2016.04.049_bib0025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0022-5347(17)40920-7","article-title":"Isolation and characterization of collagen in Peyronie's disease","volume":"141","author":"Somers","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.04.049_bib0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/j.1939-4640.1996.tb01757.x","article-title":"Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunction","volume":"17","author":"Gentile","year":"1996","journal-title":"J Androl"},{"issue":"suppl 3","key":"10.1016\/j.urology.2016.04.049_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1743-6109.2008.01195.x","article-title":"Mechanisms of penile fibrosis","author":"Gonzalez-Cadavid","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.04.049_bib0040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0090-4295(01)01578-3","article-title":"Gene expression profiles in the Peyronie's disease plaque","volume":"59","author":"Magee","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urology.2016.04.049_bib0045","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.juro.2012.01.032","article-title":"2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease","volume":"187","author":"Gelbard","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.04.049_bib0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.04.049_bib0055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","article-title":"Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire","volume":"190","author":"Hellstrom","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.04.049_bib0060","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.juro.2015.10.065","article-title":"Restoration of penile function and patient satisfaction with intralesional collagenase clostridium histolyticum injection for Peyronie's disease","volume":"195","author":"Ziegelmann","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2016.04.049_bib0065","author":"Auxilium Pharmaceuticals I"},{"key":"10.1016\/j.urology.2016.04.049_bib0070","author":"Auxilium Pharmaceuticals I"},{"key":"10.1016\/j.urology.2016.04.049_bib0075","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/jsm.13063","article-title":"Administration of collagenase clostridial histolyticum (Cch) for Peyronie's Disease","volume":"12","author":"Bennett","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2016.04.049_bib0080","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bju.13120","article-title":"Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD)","volume":"116","author":"Carson","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2016.04.049_bib0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhsa.2012.09.028","article-title":"Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data","volume":"38","author":"Peimer","year":"2013","journal-title":"J Hand Surg Am"},{"key":"10.1016\/j.urology.2016.04.049_bib0090","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie's disease: AUA guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429516302047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429516302047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T08:09:34Z","timestamp":1718525374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429516302047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":17,"alternative-id":["S0090429516302047"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2016.04.049","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peyronie's Disease and Injectable Collagenase Clostridium histolyticum: Safety, Efficacy, and Improvements in Subjective Symptoms","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2016.04.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}